SanBio Company Limited (TYO: 4592)
Japan
· Delayed Price · Currency is JPY 1,020.00
-19.00 (-1.83%)
Nov 15, 2024, 3:45 PM JST
SanBio Company Balance Sheet
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 3,081 | 4,454 | 6,732 | 4,557 | 12,480 | 13,646 | Upgrade
|
| Cash & Short-Term Investments | 3,081 | 4,454 | 6,732 | 4,557 | 12,480 | 13,646 | Upgrade
|
| Cash Growth | -33.37% | -33.84% | 47.73% | -63.49% | -8.54% | 9.58% | Upgrade
|
| Inventory | - | - | - | 467 | 444 | 469 | Upgrade
|
| Other Current Assets | 357 | 483 | 235 | 327 | 207 | 511 | Upgrade
|
| Total Current Assets | 3,438 | 4,937 | 6,967 | 5,351 | 13,131 | 14,626 | Upgrade
|
| Property, Plant & Equipment | 44 | 44 | 47 | 58 | 141 | 123 | Upgrade
|
| Long-Term Investments | 31 | 21 | 28 | 34 | 16 | 841 | Upgrade
|
| Other Intangible Assets | 43 | 43 | 1 | 66 | 53 | 13 | Upgrade
|
| Other Long-Term Assets | 2 | 2 | 2 | 1 | 2 | 2 | Upgrade
|
| Total Assets | 3,558 | 5,047 | 7,045 | 5,510 | 13,343 | 15,605 | Upgrade
|
| Accounts Payable | - | 1 | 1 | 1 | 1 | - | Upgrade
|
| Accrued Expenses | 169 | 494 | 374 | 472 | 561 | 339 | Upgrade
|
| Short-Term Debt | - | - | - | - | 500 | - | Upgrade
|
| Current Portion of Long-Term Debt | 268 | 268 | 268 | 512 | 975 | 500 | Upgrade
|
| Current Income Taxes Payable | 203 | 133 | 331 | 462 | 424 | 296 | Upgrade
|
| Other Current Liabilities | 9 | 9 | 116 | 16 | 7 | 40 | Upgrade
|
| Total Current Liabilities | 649 | 905 | 1,090 | 1,463 | 2,468 | 1,175 | Upgrade
|
| Long-Term Debt | 263 | 397 | 665 | 2,012 | 2,525 | 3,500 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1,074 | 952 | 860 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 1 | 1 | 2 | - | 1 | - | Upgrade
|
| Total Liabilities | 1,987 | 2,255 | 2,617 | 3,475 | 4,994 | 4,675 | Upgrade
|
| Common Stock | 1,495 | 3,316 | 6,407 | 4,075 | 5,561 | 8,083 | Upgrade
|
| Additional Paid-In Capital | 5,207 | 7,027 | 10,118 | 7,786 | 9,272 | 11,795 | Upgrade
|
| Retained Earnings | 874 | -1,950 | -8,177 | -9,057 | -7,356 | -9,017 | Upgrade
|
| Comprehensive Income & Other | -6,004 | -5,601 | -3,920 | -769 | 872 | 69 | Upgrade
|
| Shareholders' Equity | 1,571 | 2,792 | 4,428 | 2,035 | 8,349 | 10,930 | Upgrade
|
| Total Liabilities & Equity | 3,558 | 5,047 | 7,045 | 5,510 | 13,343 | 15,605 | Upgrade
|
| Total Debt | 531 | 665 | 933 | 2,524 | 4,000 | 4,000 | Upgrade
|
| Net Cash (Debt) | 2,550 | 3,789 | 5,799 | 2,033 | 8,480 | 9,646 | Upgrade
|
| Net Cash Growth | -33.33% | -34.66% | 185.24% | -76.03% | -12.09% | 14.56% | Upgrade
|
| Net Cash Per Share | 37.95 | 58.00 | 100.12 | 39.26 | 163.75 | 188.71 | Upgrade
|
| Filing Date Shares Outstanding | 68.63 | 68.63 | 64.85 | 53.25 | 51.79 | 51.78 | Upgrade
|
| Total Common Shares Outstanding | 68.63 | 67.93 | 64.08 | 51.79 | 51.79 | 51.78 | Upgrade
|
| Working Capital | 2,789 | 4,032 | 5,877 | 3,888 | 10,663 | 13,451 | Upgrade
|
| Book Value Per Share | 22.89 | 41.10 | 69.11 | 39.29 | 161.22 | 211.07 | Upgrade
|
| Tangible Book Value | 1,528 | 2,749 | 4,427 | 1,969 | 8,296 | 10,917 | Upgrade
|
| Tangible Book Value Per Share | 22.26 | 40.47 | 69.09 | 38.02 | 160.20 | 210.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.